Antiretroviral therapy recommendations for the global community: aspiration versus reality

AIDS. 2014 Apr 24;28(7):939-41. doi: 10.1097/QAD.0000000000000171.

Authors

Andrew N Phillips¹, Paula Munderi, Paul A Revill, Wafaa M El-Sadr, Jens D Lundgren

Affiliation

¹ aResearch Department of Infection & Population Health, University College London, London, UK bMRC/UVRI Uganda Research Unit on AIDS, Uganda cUniversity of York, York, UK dIndustrial and Commercial Abatement Program, Colombia University, New York, New York, USA eCHIP @ Department of Infectious Diseases (8632), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

PMID: 24378756
DOI: 10.1097/QAD.0000000000000171

No abstract available

MeSH terms

Anti-Retroviral Agents / therapeutic use*
Antiretroviral Therapy, Highly Active / methods*
CD4 Lymphocyte Count
Cost-Benefit Analysis
Global Health
Guidelines as Topic
HIV Infections / diagnosis*
HIV Infections / drug therapy*
HIV Infections / prevention & control
HIV Infections / transmission
Humans
Models, Theoretical
Time Factors

Substances

Anti-Retroviral Agents

Grants and funding